Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Frontiers in Oncology|February 6, 2023
Combined iodine-125 seed strand, portal vein stent, transarterial chemoembolization, lenvatinib and anti-PD-1 antibodies therapy for hepatocellular carcinoma and Vp4 portal vein tumor thrombus: A propensity-score analysisZi-Han Zhang, Si-Nan Hou, Jia-Ze Yu, et al.
Cardiovascular and Interventional Radiology|September 23, 2020
Prognosis Nomogram for Hepatocellular Carcinoma Patients with Portal Vein Invasion Undergoing Transarterial Chemoembolization Plus Sorafenib Treatment: A Retrospective Multicentre StudyLei Zhang, Jun-Hui Sun, Zhong-Heng Hou, et al.
Frontiers in Oncology|January 4, 2021
Prognostic Performance of Albumin-Bilirubin Grade With Artificial Intelligence for Hepatocellular Carcinoma Treated With Transarterial Chemoembolization Combined With SorafenibBin-Yan Zhong, Zhi-Ping Yan, Jun-Hui Sun, et al.
Zhonghua Yi Xue Za Zhi|October 28, 2005
[Diagnosis and management for early hepatic artery thrombosis after liver transplantation]Jian Zhou, Jia Fan, Ying-hao Shen, et al.
Liver Cancer|April 2, 2026
Impact of Procedural Quality on Outcomes of Transarterial Chemoembolization for Hepatocellular Carcinoma: A Multicenter StudyNan Jiang, Wen Zhang, Zhenwei Peng, et al.
Oncotarget|January 12, 2017
Endovascular brachytherapy combined with portal vein stenting and transarterial chemoembolization improves overall survival of hepatocellular carcinoma patients with main portal vein tumor thrombusTian-Zhu Yu, Wen Zhang, Qing-Xin Liu, et al.
Hepatobiliary Surgery and Nutrition|June 11, 2026
Precision transarterial chemoembolization in hepatocellular carcinoma: patient selection, standardized techniques, and quantitative evaluationBin-Yan Zhong, Zhongzhi Jia, Ho-Young Song, et al.
Hepatology (Baltimore, Md.)|August 29, 2021
Regulator of G-protein signaling 14 protects the liver from ischemia-reperfusion injury by suppressing TGF-β-activated kinase 1 activationJia-Kai Zhang, Ming-Jie Ding, Hui Liu, et al.
Cardiovascular and Interventional Radiology|February 27, 2024
Transarterial Chemoembolization with Epirubicin-Loaded Microspheres for Hepatocellular Carcinoma: A Prospective, Single-Arm, Multicenter, Phase 2 Study (STOPPER Trial)Hai-Dong Zhu, Xiao Li, Jun-Hui Sun, et al.
Frontiers in Oncology|October 26, 2020
Deep Learning Predicts Overall Survival of Patients With Unresectable Hepatocellular Carcinoma Treated by Transarterial Chemoembolization Plus SorafenibLei Zhang, Wei Xia, Zhi-Ping Yan, et al.
Pageof 9